A new positive/negative selectable marker, puDeltatk, for use in embryonic stem cells.
about
Rapid and quantitative detection of homologous and non-homologous recombination events using three oligonucleotide MLPA.GDNF Overexpression from the Native Locus Reveals its Role in the Nigrostriatal Dopaminergic System FunctionRAD51 mutants cause replication defects and chromosomal instabilityA genetic screen using the PiggyBac transposon in haploid cells identifies Parp1 as a mediator of olaparib toxicityMosaic complementation demonstrates a regulatory role for myosin VIIa in actin dynamics of stereociliaA recessive genetic screen for host factors required for retroviral infection in a library of insertionally mutated Blm-deficient embryonic stem cells.Enzymatic engineering of the porcine genome with transposons and recombinases.A homozygous mutant embryonic stem cell bank applicable for phenotype-driven genetic screening.A resource of vectors and ES cells for targeted deletion of microRNAs in mice.Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac.Sox2(+) adult stem and progenitor cells are important for tissue regeneration and survival of mice.Conditional transgenic mouse models: from the basics to genome-wide sets of knockouts and current studies of tissue regeneration.Of mice and models: improved animal models for biomedical research.The phenotype of FancB-mutant mouse embryonic stem cells.Quantification of factors influencing fluorescent protein expression using RMCE to generate an allelic series in the ROSA26 locus in miceTrex2 enables spontaneous sister chromatid exchanges without facilitating DNA double-strand break repair.Wound healing characteristics of ICAM-1 null mice devoid of all isoforms of ICAM-1.Isolation of homozygous mutant mouse embryonic stem cells using a dual selection system.ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneuronsBoth TALENs and CRISPR/Cas9 directly target the HBB IVS2-654 (C > T) mutation in β-thalassemia-derived iPSCsEfficient derivation and genetic modifications of human pluripotent stem cells on engineered human feeder cell lines.Pigs taking wing with transposons and recombinases.Contemporary approaches for modifying the mouse genomeCo-incident insertion enables high efficiency genome engineering in mouse embryonic stem cells.Probing human cardiovascular congenital disease using transgenic mouse models.Inducible gene trapping with drug-selectable markers and Cre/loxP to identify developmentally regulated genes.Bigenic Cre/loxP, puDeltatk conditional genetic ablation.Mobilization of giant piggyBac transposons in the mouse genome.Development of a model of sacrocaudal spinal cord injury in cloned Yucatan minipigs for cellular transplantation research.Pur-alpha functionally interacts with FUS carrying ALS-associated mutations.RMCE-ASAP: a gene targeting method for ES and somatic cells to accelerate phenotype analyses.Mutant nucleophosmin and cooperating pathways drive leukemia initiation and progression in miceGeneration of precise point mutation mice by footprintless genome modification.Site-specific chromosomal gene insertion: Flp recombinase versus Cas9 nuclease.Tissue regeneration using endothelial colony-forming cells: promising cells for vascular repair.Microhomology-assisted scarless genome editing in human iPSCs.HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologies.
P2860
Q24810631-4F03F125-092D-4CFD-A192-E2D3A05B7ECCQ27309907-CB5192DD-9709-453F-B98C-44F02A72BE40Q28115721-ADEEBB37-1E5A-4DF9-8A9C-3D8B34726B3CQ28487036-F3CA7BA4-F8D4-48AE-B37B-1EEED91908D5Q30481360-AFE4F138-70C5-48B6-AA64-385DE059E49BQ30830915-E5E8FFA7-A93E-4DF4-A048-2813C4A0E457Q33291228-65FA3C07-C36D-4888-A162-BCE0D90D6294Q33454079-6E5EA9A5-7099-4A21-A945-A62608E0C10FQ33984727-C70706BD-DC89-4EF0-BCFF-A1885FC4AD5CQ34153816-C9BC659F-297E-417F-9246-47A8EFAE9395Q34222321-DD584272-9957-4DF8-B6EC-44A099D22AB8Q34756517-B4A31993-3C85-4644-9D49-816CBF308A9FQ35016224-7DDF7839-5951-49AB-A4B7-DE2EAF73D650Q35028148-B9FCA0FA-D6A3-4836-8340-7DA87920D840Q35070733-5FC0B62E-4197-4712-BAA4-8FA7338DAB4CQ35221456-50E55FBD-82FF-44FD-AC75-5ADB234557DEQ35376606-1A8CB5D5-61DE-44FD-B2F8-1DD900DAFF34Q35740599-CCC960F4-C720-46CA-B09B-DBD13B18E4A9Q35802889-49C203DA-615D-480A-9A9A-75429687F0C2Q35834273-94B3AE36-41B9-41DC-B3A3-77F1C3C9A605Q36138514-092A66E7-6F1F-4574-9240-0A230FEDE91BQ36187528-9842E6BB-DD70-4043-B8F6-209F2643D026Q36846842-3FBC317A-8247-46C2-9C83-1C91A2AB4A55Q37264419-119A7932-B13D-4D92-92F7-3686EB3FC285Q37425652-233F3317-D30A-43B5-80C9-873436A93C6FQ37598783-5D0715B3-00D3-42FF-9C9A-0C844BE41AEDQ37694228-AFE02888-0688-407D-9D4D-F6A0308248C6Q39826562-60B3F840-4CC3-4D01-86CA-A53AEAFF126EQ41224473-5479B079-3AA7-4C95-A0B7-DD9DF5819897Q41880989-3A960E65-4C04-4356-8D1A-660555C89080Q41900942-0380982B-63F2-49C8-A1FA-212F3BB15294Q41959338-CB57122F-1A27-4CC2-B700-7714A1D437D1Q43729214-9228C8BA-2E18-4680-8272-BC596862D362Q47100925-E7C6AA45-42C0-497F-9E47-BD0E4DC96912Q50068661-D1561EBC-BF8E-4418-8440-F130216FA47EQ52430597-63E52367-B81D-46A2-A4A3-E3D8DD63DD6EQ55190209-B484F6B5-731D-40DA-B5AB-A143ABCF96E5
P2860
A new positive/negative selectable marker, puDeltatk, for use in embryonic stem cells.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
A new positive/negative selectable marker, puDeltatk, for use in embryonic stem cells.
@en
A new positive/negative selectable marker, puDeltatk, for use in embryonic stem cells.
@nl
type
label
A new positive/negative selectable marker, puDeltatk, for use in embryonic stem cells.
@en
A new positive/negative selectable marker, puDeltatk, for use in embryonic stem cells.
@nl
prefLabel
A new positive/negative selectable marker, puDeltatk, for use in embryonic stem cells.
@en
A new positive/negative selectable marker, puDeltatk, for use in embryonic stem cells.
@nl
P2860
P1433
P1476
A new positive/negative selectable marker, puDeltatk, for use in embryonic stem cells.
@en
P2093
P2860
P356
10.1002/1526-968X(200009)28:1<31::AID-GENE40>3.0.CO;2-K
P577
2000-09-01T00:00:00Z